Stereax Commercialization ProgressMoving from lab development to qualified manufacturing and initial purchase orders materially de-risks commercialization. Customer deliveries and cathode purchase orders create durable pathways to recurring product and NRE revenues, validating manufacturability and accelerating customer adoption over the next 2-6 months.
Goliath Prototyping And UKBIC Scale-upDemonstrated compatibility with gigafactory equipment and improved yields materially reduces scale-up and commercialization risk. Validated pilot and automated lines plus 10 Ah prototype shipments give structural confidence that production can scale, supporting longer-term licensing and OEM integration timelines.
IP Strength And Asset-light Licensing ModelA 78-patent portfolio combined with an asset-light licensing approach creates scalable revenue levers with lower capex needs. This structural go-to-market reduces capital intensity, supports higher margin potential long term, and enables multiple revenue streams as partners commercialize the tech.